The 6 analysts offering 12-month price forecasts for Voyager Therapeutics Inc have a median target of 5.50, with a high estimate of 9.00 and a low estimate of 3.00. The median estimate represents a +93.66% increase from the last price of 2.84.
The current consensus among 9 polled investment analysts is to Hold stock in Voyager Therapeutics Inc. This rating has held steady since December, when it was unchanged from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.62
Reporting Date Mar 16
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.